Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Computational methods-guided design of modulators targeting protein-protein interactions (PPIs)
Yuran Qiu, Xinyi Li, Xinheng He, et al.
European Journal of Medicinal Chemistry (2020) Vol. 207, pp. 112764-112764
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Rational Design of Peptide-Based Inhibitors Disrupting Protein-Protein Interactions
Xuefei Wang, Duan Ni, Yaqin Liu, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 104
fastDRH: a webserver to predict and analyze protein–ligand complexes based on molecular docking and MM/PB(GB)SA computation
Zhe Wang, Hong Pan, Huiyong Sun, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 5
Closed Access | Times Cited: 82
Mechanism of allosteric activation of SIRT6 revealed by the action of rationally designed activators
Shaoyong Lu, Ying-Yi Chen, Jiacheng Wei, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 5, pp. 1355-1361
Open Access | Times Cited: 73
Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies
Mohammad Hassan Baig, Khurshid Ahmad, Jun Sung Moon, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 56
De novo molecular design with deep molecular generative models for PPI inhibitors
Jianmin Wang, Yanyi Chu, Jiashun Mao, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 4
Closed Access | Times Cited: 44
Translational aspect in peptide drug discovery and development: An emerging therapeutic candidate
Uttpal Anand, Anustup Bandyopadhyay, Niraj Kumar Jha, et al.
BioFactors (2022) Vol. 49, Iss. 2, pp. 251-269
Open Access | Times Cited: 37
Untangling Dual-Targeting Therapeutic Mechanism of Epidermal Growth Factor Receptor (EGFR) Based on Reversed Allosteric Communication
Yuran Qiu, Xiaolan Yin, Xinyi Li, et al.
Pharmaceutics (2021) Vol. 13, Iss. 5, pp. 747-747
Open Access | Times Cited: 46
Aconitine and its derivatives: bioactivities, structure-activity relationships and preliminary molecular mechanisms
Pengyu Zhao, Ye Tian, Yuefei Geng, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 6
Molecular glues and induced proximity: An evolution of tools and discovery
Stephanie Anne Robinson, J Co, Steven M. Banik
Cell chemical biology (2024) Vol. 31, Iss. 6, pp. 1089-1100
Closed Access | Times Cited: 6
Molecular Glue-Design-Evaluator (MOLDE): An Advanced Method for In-Silico Molecular Glue Design
Ben Geoffrey A S, Deepak Agrawal, Nagaraj M. Kulkarni, et al.
ACS Omega (2025) Vol. 10, Iss. 7, pp. 6650-6662
Open Access
In vitro simulated gastrointestinal digestion stability and in vivo antihypertensive effect of the peptide KYPHVF and its network pharmacology
Renjuan Li, Yongliang Zhuang, Lin Lin, et al.
Journal of Functional Foods (2023) Vol. 107, pp. 105672-105672
Open Access | Times Cited: 12
New insights into protein–protein interaction modulators in drug discovery and therapeutic advance
Hossam Nada, Yongseok Choi, Sung-Do Kim, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Design, synthesis, evaluation, and SAR of 4-phenylindoline derivatives, a novel class of small-molecule inhibitors of the programmed cell death-1/ programmed cell death-ligand 1 (PD-1/PD-L1) interaction
Yang Yang, Ke Wang, Hao Chen, et al.
European Journal of Medicinal Chemistry (2020) Vol. 211, pp. 113001-113001
Closed Access | Times Cited: 33
DLiP-PPI library: An integrated chemical database of small-to-medium-sized molecules targeting protein–protein interactions
Kazuyoshi Ikeda, Yuta Maezawa, Tomoki Yonezawa, et al.
Frontiers in Chemistry (2023) Vol. 10
Open Access | Times Cited: 11
Innovative peptide architectures: advancements in foldamers and stapled peptides for drug discovery
Zhou Dongrui, Maho Miyamoto, Hidetomo Yokoo, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 6, pp. 699-723
Closed Access | Times Cited: 3
Unlocking the microbial studies through computational approaches: how far have we reached?
Rajnish Kumar, Garima Yadav, Mohammed Kuddus, et al.
Environmental Science and Pollution Research (2023) Vol. 30, Iss. 17, pp. 48929-48947
Open Access | Times Cited: 8
Helical Foldamers and Stapled Peptides as New Modalities in Drug Discovery: Modulators of Protein-Protein Interactions
Keisuke Tsuchiya, Takashi Kurohara, Kiyoshi Fukuhara, et al.
Processes (2022) Vol. 10, Iss. 5, pp. 924-924
Open Access | Times Cited: 13
Molecular Dynamics Simulation-Driven Focused Virtual Screening and Experimental Validation of Inhibitors for MTDH-SND1 Protein–Protein Interaction
Ya-Di Xu, Xiao-Yu Guo, Dengjie Yan, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 11, pp. 3614-3627
Closed Access | Times Cited: 7
In silico structural modeling and quality assessment of Plasmodium knowlesi apical membrane antigen 1 using comparative protein models
Haron F.N.
Tropical biomedicine (2022) Vol. 39, Iss. 3, pp. 394-401
Open Access | Times Cited: 10
Effect of FKBP12-Derived Intracellular Peptides on Rapamycin-Induced FKBP–FRB Interaction and Autophagy
Carolina A. Parada, Ivan Pires de Oliveira, Mayara C. F. Gewehr, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 385-385
Open Access | Times Cited: 9
Advancements, challenges, and future frontiers in covalent inhibitors and covalent drugs: A review
Muhammad Salman Hameed, Hongxuan Cao, Li Guo, et al.
European Journal of Medicinal Chemistry Reports (2024), pp. 100217-100217
Open Access | Times Cited: 1
Targeting protein-protein interactions in drug discovery: Modulators approved or in clinical trials for cancer treatment
Cristina Camps-Fajol, Debora Cavero, Jordi Minguillón, et al.
Pharmacological Research (2024) Vol. 211, pp. 107544-107544
Open Access | Times Cited: 1
A review on cullin neddylation and strategies to identify its inhibitors for cancer therapy
Iqra Bano, Moolchand Malhi, Min Zhao, et al.
3 Biotech (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 8
Biophysical and Integrative Characterization of Protein Intrinsic Disorder as a Prime Target for Drug Discovery
Shuqi Luo, Samuel Wohl, Wenwei Zheng, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 530-530
Open Access | Times Cited: 4
Development of novel PEX5-PEX14 protein-protein interaction (PPI) inhibitors based on an oxopiperazine template
Monika Marciniak, Piotr Mróz, Valeria Napolitano, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115587-115587
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top